From serendipity to science

Good Clinical Practice Journal

Volumn 12, Issue 5, 2005, Pages 25-27

  Skare, Kevin ^a   Sietsema, William ^b  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^b Clinical Regulatory Strategic Planning Kendle   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIVIRUS AGENT; PLACEBO; TRANEXAMIC ACID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; CLINICAL RESEARCH; CLINICAL STUDY; CLINICAL TRIAL; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG RESEARCH; DRUG SAFETY; ECONOMIC ASPECT; EXPERIMENTAL DESIGN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISCHIALGIA; JOINT DESTRUCTION; MEDICAL DECISION MAKING; METHODOLOGY; NONHUMAN; OSTEOLYSIS; PATIENT COMPLIANCE; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; RISK FACTOR; VIRUS LOAD;

EID: 31744447816     PISSN: 13500961     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. E Schmutzhard, K Engelhardt, R Beer, et al. 'Safety and efficacy of a novel intravascular cooling device to control body temperature in neurology intensive care patients: A prospective pilot study', Critical Care Medicine, 30(11), pp2481-2488, 2002.
2. WH van der Laan, HK Ronday, JM TeKoppele, et al. 'No therapeutic effect of plasmin antagonist tranexamic acid in rheumatoid arthritis. A double-blind placebo-controlled pilot study', Clinical and Experimental Rheumatology, 21(3), pp359-362, 2003.
3. S Genevay, S Stingelin, C Gabay. 'Efficacy of etanercept in the treatment of acute, severe sciatica: A pilot study', Annals of the Rheumatic Diseases, 63(9), pp 1120-1123, 2004.
4. M Dybul, E Nies-Kraske, R Dewar, et al. 'A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection', Journal of Infectious Diseases, 189(11), pp1974-1982, 2004.